Prognostic relevance of tumor‑infiltrating lymphocytes in residual tumor tissue from patients with triple‑negative breast cancer following neoadjuvant chemotherapy: A …
B Cao, Z Zhang, C Wang, X Lv - Oncology Letters, 2023 - spandidos-publications.com
Further adjuvant chemotherapy treatment can provide benefits to certain patients with triple‑
negative breast cancer (TNBC) that fail to achieve pathological complete response (pCR) …
negative breast cancer (TNBC) that fail to achieve pathological complete response (pCR) …
[HTML][HTML] One-pot method for preparing DNA, RNA, and protein for multiomics analysis
S Biedka, D Alkam, CL Washam, S Yablonska… - Communications …, 2024 - nature.com
Typical multiomics studies employ separate methods for DNA, RNA, and protein sample
preparation, which is labor intensive, costly, and prone to sampling bias. We describe a …
preparation, which is labor intensive, costly, and prone to sampling bias. We describe a …
Ganoderma lucidum spores-derived particulate β-glucan treatment improves antitumor response by regulating myeloid-derived suppressor cells in triple-negative …
Y Bu, Q Liu, Y Shang, Z Zhao, H Sun, F Chen… - International Journal of …, 2024 - Elsevier
Abstract Granular β-1, 3-glucan extracted from the wall of Ganoderma lucidum spores,
named GPG, is a bioregulator. In this study, we investigated the structural, thermal, and other …
named GPG, is a bioregulator. In this study, we investigated the structural, thermal, and other …
[HTML][HTML] Dendritic cell subpopulations are associated with morphological features of breast ductal carcinoma in situ
J Szpor, J Streb, A Glajcar, A Streb-Smoleń… - International Journal of …, 2023 - mdpi.com
Ductal carcinoma in situ (DCIS) is the preinvasive form of breast cancer (BC). It is disputed
whether all cases of DCIS require extensive treatment as the overall risk of progression to …
whether all cases of DCIS require extensive treatment as the overall risk of progression to …
[HTML][HTML] Matrix Metalloproteinase-9 Expression Is Associated with the Absence of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients
M Lejeune, L Reverté, N Gallardo, E Sauras… - International Journal of …, 2023 - mdpi.com
Triple-negative breast cancer (TNBC) is particularly challenging due to the weak or absent
response to therapeutics and its poor prognosis. The effectiveness of neoadjuvant …
response to therapeutics and its poor prognosis. The effectiveness of neoadjuvant …